Practices Core
实践核心
基本信息
- 批准号:10793944
- 负责人:
- 金额:$ 72.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-18 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PRACTICES CORE
ABSTRACT:
The Regional Biocontainment Laboratory (RBL) within the Center for Vaccine Research (CVR) at the University
of Pittsburgh is the biosafety level-3 (BSL-3) hub for infection biology. The mission of the RBL is threefold, to
work on pathogen emergence, evolution and host-to-host transmission, to study the pathogenesis of
emerging infectious diseases and to accelerate pre-clinical development of novel interventions and medical
countermeasures for pandemic preparedness and biodefense. Our vision is to be a globally recognized, highly-
collaborative, creative and forward-facing team of infection biologists who are poised to respond to emerging
biological threats both at the national and international level. The entire facility is registered with the Division of
Select Agents and Toxins (DSAT). It brings together infection biologists and clinicians from a variety of disciplines
who require BSL-3 and animal (A)BSL-3 facilities for their wide ranging viral and bacterial research programs.
Biocontainment work is operationally complex, infrastructure-dense, and comprehensively regulated. Running
BSL-3 laboratories safely, securely and successfully demands having a well-organized and highly integrated
team of administrators, scientists, biosafety/biosecurity professionals, engineers/facilities staff and
veterinarians/zootechnical staff. This is especially important in multi-pathogen, multi-user research facilities that
study standard and select agent BSL-3 pathogens. The Practices Core will support all the basic functions of the
RBL enabling scientific programs to be rigorously managed and ensuring overall data integrity for reproducible
outcomes. It will provide the requisite theoretical and practical trainings to onboard new RBL Investigators and
their teams who wish to work in BSL-3 and ABSL-3 biocontainment. It will provide biosafety and biosecurity
support and guarantee the facility meets all current compliance regulations for Tier 1 select agent registered
laboratories. Provision of technical and support for the RBL in Pittsburgh will ensure we are ready to respond to
any national response to a range of emerging infectious diseases in the event of another pandemic or
bioterrorism attack. Supporting this cohort of BSL-3 scientists, who can pivot to work on new pathogens in an
emergency, is certain to pay dividends.
实践核心
抽象的:
大学疫苗研究中心(CVR)内的区域生物内在实验室(RBL)
匹兹堡的属于感染生物学的生物安全3级(BSL-3)中心。 RBL的任务是三倍,
在病原体出现,进化和宿主传播方面的工作,以研究
新兴的传染病,并加速新的干预措施和医学的临床前发展
大流行准备和生物陷入困境的对策。我们的愿景是成为全球认可的,高度的 -
准备回应新兴的感染生物学家的合作,创造性和正面的感染生物学家团队
国家和国际层面都有生物威胁。整个设施已在部门注册
选择剂和毒素(DSAT)。它汇集了来自各种学科的感染生物学家和临床医生
他们需要BSL-3和动物(A)BSL-3设施来进行广泛的病毒和细菌研究计划。
生物内在的工作在操作上是复杂的,基础设施密集的,并且经过全面调节。跑步
BSL-3实验室安全,安全,成功地要求拥有良好的整合且高度整合
管理员,科学家,生物安全/生物安全专业人员,工程师/设施人员以及
兽医/Zootechnical员工。这在多病原,多用户研究设施中尤其重要
研究标准和选择剂BSL-3病原体。实践核心将支持
RBL使科学计划得到严格管理并确保可重复的总体数据完整性
结果。它将为新的RBL调查人员提供必要的理论和实用培训
希望在BSL-3和ABSL-3生物内生化的团队。它将提供生物安全和生物安全性
支持和保证该设施符合第1层的所有当前合规性法规注册
实验室。在匹兹堡为RBL提供技术和支持,将确保我们准备回应
在另一个大流行或
生物恐怖主义攻击。支持这一BSL-3科学家,他们可以枢转工作
紧急情况,肯定会偿还股息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
William Paul Dupre...的其他基金
Administrative Supplement for Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research
升级匹兹堡大学疫苗研究中心区域生物防护实验室的行政补充
- 批准号:1063133910631339
- 财政年份:2022
- 资助金额:$ 72.71万$ 72.71万
- 项目类别:
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization
开发用于中和 SARS-CoV-2 的多价、超强纳米抗体混合物
- 批准号:1044444210444442
- 财政年份:2022
- 资助金额:$ 72.71万$ 72.71万
- 项目类别:
Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research
升级疫苗研究中心内的匹兹堡大学区域生物防护实验室
- 批准号:1039447410394474
- 财政年份:2021
- 资助金额:$ 72.71万$ 72.71万
- 项目类别:
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
转变疫苗安全范式:从经验衰减到理性衰减
- 批准号:86643408664340
- 财政年份:2013
- 资助金额:$ 72.71万$ 72.71万
- 项目类别:
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
转变疫苗安全范式:从经验衰减到理性衰减
- 批准号:85044838504483
- 财政年份:2013
- 资助金额:$ 72.71万$ 72.71万
- 项目类别:
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
转变疫苗安全范式:从经验衰减到理性衰减
- 批准号:90647409064740
- 财政年份:2013
- 资助金额:$ 72.71万$ 72.71万
- 项目类别:
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
转变疫苗安全范式:从经验衰减到理性衰减
- 批准号:88525308852530
- 财政年份:2013
- 资助金额:$ 72.71万$ 72.71万
- 项目类别:
相似国自然基金
问责制度何以影响地方政府绩效——目标责任制情境下的“问责悖论”研究
- 批准号:71103140
- 批准年份:2011
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Exploratory Research Project - CAT
探索性研究项目 - CAT
- 批准号:1057712110577121
- 财政年份:2023
- 资助金额:$ 72.71万$ 72.71万
- 项目类别:
Strengthening Research Administration Infrastructure for HIV Research in Nigeria
加强尼日利亚艾滋病毒研究的研究管理基础设施
- 批准号:1069315310693153
- 财政年份:2022
- 资助金额:$ 72.71万$ 72.71万
- 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
- 批准号:1062548910625489
- 财政年份:2020
- 资助金额:$ 72.71万$ 72.71万
- 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
- 批准号:1086232910862329
- 财政年份:2020
- 资助金额:$ 72.71万$ 72.71万
- 项目类别: